Drawing for A B

USPTO serial 76077758

A B

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
SMITH, BRIDGETT G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with A B?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, chemical preparations, reagents, synthetic materials, biological materials, and kits consisting primarily of chemicals, chemical preparations, reagents, synthetic materials and biological; all for use in nucleic acid sequencing, analysis, and synthesis, genetic analysis, fragment analysis, linkage analysis, electrophoresis, forensics and human identification, microbial identification, molecular microbiology, custom oligo synthesis, Polymerase Chain Reaction (PCR) and related applications, protein and peptide synthesis, fluorescence technology, cytometry, sample preparation, gene expression and gene discovery, genetic disease research, genomics, pharmacokinetic, proteomics, biotechnology consultation, research and development, life science, science, technology, medicine and health; Chemicals, chemical preparations, reagents, synthetic materials, biological materials, and kits consisting primarily of chemicals, chemical preparations, reagents, synthetic materials and biological materials; all for use in medical and diagnostics; Computer software and hardware; CD-ROMS and computer diskettes; Pre-recorded audio and video tapes and cassettes; instruments, apparatus, workstation, robotic devices, and accessories to and parts of the above instruments; Laboratory supplies and plastic consumables, rack, vials, caps, septa, needles, bottles, flask, filter, tubes, and seals, plastic tray cover, microplate, pipette tips, reagent reservoir, optical heat field covers, plastic cards; all for use in nucleic acid sequencing, analysis, and synthesis, genetic analysis, fragment analysis, linkage analysis, electrophoresis, forensics and human identification, microbial identification, molecular microbiology, nucleic acid synthesis, custom oligo synthesis, Polymerase Chain Reaction (PCR) and related applications, protein and peptide synthesis, fluorescence technology, cytometry, sample preparation, gene expression and gene discovery, genetic disease research, genomics, pharmacokinetic, proteomics, biotechnology consultation, research and development, life science, science, technology, medicine and health; Computer software and hardware; CD-ROMS and computer diskettes; Pre-recorded audio and video tapes and cassettes; instruments, apparatus, workstation, robotic devices, and accessories to and parts of the above instruments; Laboratory supplies and plastic consumables, rack, vials, caps, septa, needles, bottles, flask, filter, tubes, and seals, plastic tray cover, microplate, pipette tips, reagent reservoir, optical heat field covers, plastic cards; all for use in medical and diagnostics; consultation, research and development in the field of science, technology, medicine, health and public policy; computer services; providing information; medical, research and laboratory diagnostic services and assaying; assay systems for the performance of medical, research and laboratory diagnostic services; development of new products for others; licensing of assay systems; nucleic acid sequencing, analysis and synthesis; synthesis of oligonucleotides and other molecules; inventory control of chemicals; gene discovery; genomics, pharmacokinetic, proteomics, and gene expression; installation, maintenance and repair of systems and tools; in InternationalACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Aug 2, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 24, 2001ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 28, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance